Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses Recent Data Examining Atezolizumab And…
Browsing: Kidney
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses The Implications Of CHECKMATE 214…
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses Outcomes Of The KEYNOTE 426…
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses TIVO-3 Study In Highly Refractory…
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses How To Differentiate Between TKIs…
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses Next Steps When Treating mRCC…
Michael Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical…
Michael Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical…
Michael Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical…
Michael Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical…
Michael Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical…
Tian Zhang, MD, Assistant Professor of Medicine, Duke Cancer Institute, Discusses The Outcomes Of KEYNOTE 426 Presented At GU 2019.…
Tian Zhang, MD, Assistant Professor of Medicine, Duke Cancer Institute, Discusses Intermediate/Poor And Favorable Risk RCC Patients. At The 2019…
Tian Zhang, MD, Assistant Professor of Medicine, Duke Cancer Institute, Discusses Predictive Biomarkers In Selecting Patient Populations For I-O Treatment…
John Leppert, M.D., M.S. Associate Professor – Med Center Line, Urology At Stanford University Discusses Which Patient For Which Treatment.…
John Leppert, M.D., M.S. Associate Professor – Med Center Line, Urology At Stanford University Discusses Over-Diagnosis & Over-Treatment Of Kidney…
John Leppert, M.D., M.S. Associate Professor – Med Center Line, Urology At Stanford University Discusses Increasing Awareness In Kidney Cancer.…
John Leppert, M.D., M.S. Associate Professor – Med Center Line, Urology At Stanford University Discusses How To Better Treat Kidney…
Abhishek Tripathi, M.D. Assistant Professor Of Medicine In The Section Of Hematology/Oncology At Oklahoma Stephenson Cancer Center Discusses Adenosine Pathway…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Samra Turajlic, M.D. Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, Discusses What To Achieve With The TRACERx…
Samra Turajlic, M.D. Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, Discusses Results From TRACERx Renal Study. At…
Samra Turajlic, M.D. Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, Discusses The TRACERx Renal Study. At the…
Brian Shuch, M.D. Associate Professor of Urology at UCLA Discusses, Tumor Enucleation Debate. At the Seventeenth International Kidney Cancer Symposium…
Brian Shuch, M.D. Associate Professor of Urology at UCLA Discusses, Overview of Sessions From KCA Miami. At the Seventeenth International…
Brian Shuch, M.D. Associate Professor of Urology at UCLA Discusses, Tumor Enucleation. At the Seventeenth International Kidney Cancer Symposium on…
Brian Shuch, M.D. Associate Professor of Urology at UCLA Discusses, Benefits Of Tumor Enucleation. At the Seventeenth International Kidney Cancer…
Sumantra Kumar Pal, M.D. Assistant professor in the Department of Medical Oncology & Therapeutics Research and co-director of the Kidney…
Sumantra Kumar Pal, M.D. Assistant professor in the Department of Medical Oncology & Therapeutics Research and co-director of the Kidney…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Upcoming Data Coming In 2019. At the Seventeenth International Kidney…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Profiling Tumor Microenvironment. At the Seventeenth International Kidney Cancer Symposium…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Next Gen Immune Activation In Kidney Cancer. At the Seventeenth…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Figuring Out Best Drug Combo For Kidney Cancer. At the…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Discussing Combining Drugs In Kidney Cancer. At the Seventeenth International…
Alexander Kutikov, M.D. Chief, Division of Urology and Urologic Oncology Professor At Fox Chase Cancer Center, Department of Surgical Oncology…
Alexander Kutikov, M.D. Chief, Division of Urology and Urologic Oncology Professor At Fox Chase Cancer Center, Department of Surgical Oncology…
Steven Chang, M.D., M.S. Urologic Oncologist and Health Service Researcher at Brigham and Women’s Hospital discusses Should We Be Doing…
David Braun, M.D., Phd an Oncologist at Dana-Farber Cancer Institute in Boston MA. discusses Why Not Use Bulk RNA Sequencing…
David Braun, M.D., Phd an Oncologist at Dana-Farber Cancer Institute in Boston MA. discusses The Future Of Single Cell RNA…
David Braun, M.D., Phd an Oncologist at Dana-Farber Cancer Institute in Boston MA. discusses Single Cell RNA Sequencing In Kidney…
David Braun, M.D., Phd an Oncologist at Dana-Farber Cancer Institute in Boston MA. discusses Next Step In Single Cell RNA…
David Braun, M.D., Phd an Oncologist at Dana-Farber Cancer Institute in Boston MA. discusses Next Step In Single Cell RNA…
David Braun, M.D., Phd an Oncologist at Dana-Farber Cancer Institute in Boston MA. discusses How To Deal With Intra &…
CRISTIANE DECAT BERGEROT, PhD PSYCHOLOGIST, POSTDOCTORAL FELLOW CITY OF HOPE COMPREHENSIVE CANCER CENTER discusses THE IMPACT OF THE PSYCHOSOCIAL MILIEU…
Eric A. Singer, MD, MA, MS, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Section of Urologic…
Bellinda King-Kallimanis, PhD of U.S. Food and Drug Administration, Maryland (FDA ) discusses Incorporating Relevant and Meaningful ?Patient-Reported Outcomes in…